No.103：GLP-1によるGERD／肺癌ネオアジュバントニボルマブ化学療法

にゃんごう＆いがさんのEBMerな夜

第103回放送　2025/8/23

【にゃんごう：GLP-1によるGERD】

Noh Y, Yin H, Yu OHY, Bitton A, Azoulay L.

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes : A Population-Based Cohort Study.

Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-24-03420. Epub ahead of print.

PMID: 40658955.

https://www.acpjournals.org/doi/10.7326/ANNALS-24-03420

【いがさん：肺癌ネオアジュバントニボルマブ化学療法】

Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, Lu S, Felip E, Swanson SJ, Brahmer JR, Kerr K, Taube JM, Ciuleanu TE, Tanaka F, Saylors GB, Chen KN, Ito H, Liberman M, Martin C, Broderick S, Wang L, Cai J, Duong Q, Meadows-Shropshire S, Fiore J, Bhatia S, Girard N; CheckMate 816 Investigators.

Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

N Engl J Med. 2025 Aug 21;393(8):741-752. doi: 10.1056/NEJMoa2502931. Epub 2025 Jun 2.

PMID: 40454642.

https://www.nejm.org/doi/full/10.1056/NEJMoa2502931

リスナーアンケートにご協力下さい！！

https://goo.gl/forms/5AsPilK7QnB9VrmX2